Chien-Hsien Lai

Title: Innovations by Chien-Hsien Lai

Introduction

Chien-Hsien Lai is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations aimed at treating neoplastic diseases. His work is characterized by a focus on enhancing humoral immunity in tumors.

Latest Patents

Chien-Hsien Lai holds a patent for "Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors." This invention provides novel pharmaceutical formulations comprising derivatives of NDGA, including MN (tetra-0-methyl nordihydroguaiaretic acid) and temozolomide. These formulations are designed for the inhibition and treatment of various cancers, including glioblastoma multiforme and lung cancer.

Career Highlights

Throughout his career, Chien-Hsien Lai has worked with prestigious institutions such as The Johns Hopkins University and Academia Sinica. His research has contributed to advancements in cancer treatment and has the potential to improve patient outcomes significantly.

Collaborations

Chien-Hsien Lai has collaborated with notable colleagues, including Ru Chih C Huang and Jong Ho Chun. These partnerships have fostered innovation and have been instrumental in the development of his patented formulations.

Conclusion

Chien-Hsien Lai's work exemplifies the impact of innovative research in the pharmaceutical field. His contributions to cancer treatment through novel formulations highlight the importance of continued research and collaboration in advancing medical science.